25
IRUS Total
Downloads
  Altmetric

2018 FDA tides harvest

File Description SizeFormat 
pharmaceuticals-12-00052.pdfPublished version1.31 MBAdobe PDFView/Open
Title: 2018 FDA tides harvest
Authors: Al Shaer, D
Al Musaimi, O
Albericio, F
De la Torre, BG
Item Type: Journal Article
Abstract: In 2018, the United States Food and Drug Administration (FDA) approved a total of 59 new drugs, three of them (5%) are TIDES (or also, -tides), two oligonucleotides and one peptide. Herein, the three TIDES approved are analyzed in terms of medical target, mode of action, chemical structure, and economics.
Issue Date: 5-Apr-2019
Date of Acceptance: 3-Apr-2019
URI: http://hdl.handle.net/10044/1/88505
DOI: 10.3390/ph12020052
ISSN: 1424-8247
Publisher: MDPI AG
Start Page: 1
End Page: 6
Journal / Book Title: Pharmaceuticals
Volume: 12
Issue: 2
Copyright Statement: © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Keywords: Science & Technology
Life Sciences & Biomedicine
Chemistry, Medicinal
Pharmacology & Pharmacy
dotatate
drugs
inotersen
Lutathera
oligonucleotides
Onpattro
patisiran
peptides
pharmaceutical market
Tegsedi
Lutathera
Onpattro
Tegsedi
dotatate
drugs
inotersen
oligonucleotides
patisiran
peptides
pharmaceutical market
Science & Technology
Life Sciences & Biomedicine
Chemistry, Medicinal
Pharmacology & Pharmacy
dotatate
drugs
inotersen
Lutathera
oligonucleotides
Onpattro
patisiran
peptides
pharmaceutical market
Tegsedi
1115 Pharmacology and Pharmaceutical Sciences
Publication Status: Published
Open Access location: https://www.mdpi.com/1424-8247/12/2/52
Article Number: ARTN 52
Online Publication Date: 2019-04-05
Appears in Collections:Chemical Engineering



This item is licensed under a Creative Commons License Creative Commons